BioVie Inc (BIVI)
3.11
-0.25
(-7.44%)
USD |
NASDAQ |
Nov 21, 16:00
3.11
0.00 (0.00%)
Pre-Market: 08:07
BioVie Enterprise Value: 38.56M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 38.56M |
| November 20, 2024 | 43.00M |
| November 19, 2024 | 45.66M |
| November 18, 2024 | 43.89M |
| November 15, 2024 | 39.98M |
| November 14, 2024 | 39.80M |
| November 13, 2024 | 43.89M |
| November 12, 2024 | 42.82M |
| November 11, 2024 | 36.42M |
| November 08, 2024 | 32.16M |
| November 07, 2024 | 30.38M |
| November 06, 2024 | 26.09M |
| November 05, 2024 | 26.36M |
| November 04, 2024 | 27.87M |
| November 01, 2024 | 32.49M |
| October 31, 2024 | 31.95M |
| October 30, 2024 | 33.73M |
| October 29, 2024 | 28.76M |
| October 28, 2024 | 30.97M |
| October 25, 2024 | 30.33M |
| October 24, 2024 | 27.86M |
| October 23, 2024 | 25.56M |
| October 22, 2024 | 29.59M |
| October 21, 2024 | 7.847M |
| October 18, 2024 | 1.995M |
| Date | Value |
|---|---|
| October 17, 2024 | -7.792M |
| October 16, 2024 | -7.712M |
| October 15, 2024 | -7.951M |
| October 14, 2024 | -7.632M |
| October 11, 2024 | -7.314M |
| October 10, 2024 | -7.394M |
| October 09, 2024 | -7.076M |
| October 08, 2024 | -6.439M |
| October 07, 2024 | -7.155M |
| October 04, 2024 | -7.235M |
| October 03, 2024 | -7.314M |
| October 02, 2024 | -7.235M |
| October 01, 2024 | -7.553M |
| September 30, 2024 | -7.155M |
| September 27, 2024 | -8.626M |
| September 26, 2024 | -9.34M |
| September 25, 2024 | -8.626M |
| September 24, 2024 | -10.67M |
| September 23, 2024 | -0.4161M |
| September 20, 2024 | -0.6693M |
| September 19, 2024 | -0.2261M |
| September 18, 2024 | 0.217M |
| September 17, 2024 | 0.5336M |
| September 16, 2024 | 1.673M |
| September 13, 2024 | 1.863M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-10.67M
Minimum
Sep 24 2024
611.76M
Maximum
Feb 03 2021
115.72M
Average
95.40M
Median
Jan 10 2022
Enterprise Value Benchmarks
| Catalyst Pharmaceuticals Inc | 2.077B |
| MediciNova Inc | 53.75M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.152M |
| Total Expenses (Quarterly) | 4.122M |
| EPS Diluted (Quarterly) | -0.70 |
| Earnings Yield | -167.2% |